Reference : A direct enzyme-linked immunosorbent assay (Elisa) for antibodies to enterobacterial ...
Scientific journals : Article
Human health sciences : Anesthesia & intensive care
A direct enzyme-linked immunosorbent assay (Elisa) for antibodies to enterobacterial score glycolipid and lipid A. Results in Healthy Subjects and in Patients Infected by Gram-Negative Bacteria
Nys, Monique mailto [Centre Hospitalier Universitaire de Liège - CHU > > Soins intensifs >]
Damas, Pierre mailto [Université de Liège - ULiège > > Soins intensifs >]
Damas, François [Université de Liège - ULiège > Services généraux (Faculté de médecine) > Relations académiques et scientifiques (Médecine)]
Joassin, L. [> > > >]
Demonty, Jean mailto [Centre Hospitalier Universitaire de Liège - CHU > > Maladies infectieuses et médecine interne générale >]
Medical Microbiology & Immunology
Springer Science & Business Media B.V.
Yes (verified by ORBi)
[en] We have developed an ELISA for IgM and IgG antibodies to the core glycolipid (CGL) of the Re mutant Salmonella minnesota R 595, and to lipid A. Anti-CGL antibodies have been detected in sera from 37% of healthy blood donors, whereas anti-lipid A activities were found in 13% of individuals only. The anti-CGL and anti-lipid A activities were examined in patients in a surgical intensive care unit, selected on the basis of a definite risk of infectious complications due to Gram-negative bacteria. Of the patients who developed such infections, the rate of favourable outcome was significantly higher in patients with either stable positive or increasing anti-CGL activities than in patients found to be negative. Our results provide clear evidence that anti-CGL antibodies contribute to host defence against various Gram-negative bacteria.
Researchers ; Professionals

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.